First Eagle Investment Management
MDCO

First Eagle Investment Management’s Medicines Co MDCO Stock Holding History

First Eagle Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-409,112
Closed -$34.8M – 120
2019
Q4 		$34.8M Sell
409,112
-354,900
-46% -$23.7M 0.1% 78
2019
Q3 		$38.2M Buy
764,012
+285,639
+60% +$11.4M 0.11% 76
2019
Q2 		$17.4M Sell
478,373
-14,500
-3% -$473K 0.05% 99
2019
Q1 		$13.8M Buy
492,873
+45,838
+10% +$1.08M 0.04% 112
2018
Q4 		$8.56M Buy
447,035
+94,167
+27% +$2.19M 0.02% 119
2018
Q3 		$10.6M Hold
352,868
– – 0.03% 128
2018
Q2 		$12.9M Sell
352,868
-112,995
-24% -$3.67M 0.03% 124
2018
Q1 		$15.3M Hold
465,863
– – 0.04% 123
2017
Q4 		$12.7M Hold
465,863
– – 0.03% 142
2017
Q3 		$17.3M Sell
465,863
-323,151
-41% -$11.9M 0.04% 145
2017
Q2 		$30M Sell
789,014
-201,885
-20% -$8.99M 0.07% 130
2017
Q1 		$48.5M Sell
990,899
-64,130
-6% -$2.92M 0.12% 105
2016
Q4 		$35.8M Buy
1,055,029
+34,400
+3% +$1.22M 0.09% 126
2016
Q3 		$38.5M Buy
1,020,629
+465,530
+84% +$17.5M 0.1% 130
2016
Q2 		$18.7M Buy
+555,099
New +$19.6M 0.05% 158

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

First Eagle Investment Management's MDCO Position: Q1 2020 in Review

First Eagle Investment Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 409,112 shares — an estimated $34.8M sold.

First Eagle Investment Management first reported a position in MDCO in Q2 2016 and held it in 15 quarters. The position peaked at $48.5M in Q1 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • First Eagle Investment Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • First Eagle Investment Management sold 409,112 Medicines Co shares in Q1 2020, an estimated $34.8M.
  • First Eagle Investment Management first reported a position in Medicines Co in Q2 2016 and held it in 15 quarters.
  • First Eagle Investment Management's Medicines Co position peaked at $48.5M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on First Eagle Investment Management's 13F filing for Q1 2020, filed 12 May 2020.